Geneuity works with small Pharma, Biotech, Contract Research Organizations, and Medical Device companies to design and perform biomarker analysis based on development needs.
Understanding the specific needs of a clinical trial is the first step in ensuring the most appropriate testing is performed. Timely results identify patient recruitment targets and deliver successful clinical trial outcomes by reducing time to FDA submission, minimizing risks of rejection and cost of trial.
Geneuity’s expert group of board certified pathologists and scientists can help to assess biomarkers and testing panels for patient recruitment and on-going trial monitoring. Geneuity brings more than a decade of experience in operation as a CLIA certified and CAP accredited molecular diagnostic laboratory providing a consultative approach to laboratory testing.
Access to pathology resource
Phase I, II, III specialty laboratory testing
Biomarker selection / consultation
Biomarker assay development
Companion diagnostic selection/validation
Clinical study proof of concept
Contract Research Organization
Outsourced testing for Phase I, II and III
- Anatomic Pathology
- Molecular Diagnostics
- Flow Cytometry
- Fluorescence in situ Hybridization
Patient selection screening